Atlas Trials

Efficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 Patients

Clinical trial NCT04472728 · TERMINATED

Trial details

NCT number
NCT04472728
Sponsor
Biophytis
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Covid-19SARS-CoV2
Start date
2020-08-26
Primary completion
2022-06-06
Enrollment
238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.